1st Quarter - Report

AMERICAN KIDNEY FUND for AMERICAN KIDNEY FUND

Firm
Client
Income
—
Expenses
$280,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Living Donor Protection Act Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2025 Honor Our Living Donors Act Restore Protections for Dialysis Patients Act Medicaid Education Staffing for Organ Procurement and Transplantation Network modernization initiative Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability (CMS-9884-P) Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-P)

LobbyistCovered position, as disclosed
HOLLY A. BODE —
DEBORAH DARCY —
SCOTT MOORE New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.